Close
FINDING CURES TOGETHER<sup>SM</sup>
Julian Blagg, DPhil

Chairperson
Julian Blagg, DPhil
(2018-2019)
Deputy Director, Head of Chemistry
​Institute of Cancer Research
London, UK

Andrew J. Phillips, PhD

Chairperson-elect
Andrew J. Phillips, PhD
(2018-2019)
President and Chief Scientific Officer
​C4 Therapeutics
Cambridge, Massachusetts

Melissa M. Vasbinder, PhD

Past Chairperson
Melissa M. Vasbinder, PhD
(2018-2019)
Associate Director, Medicinal Chemistry
Ribon Therapeutics, Inc.​
Wellesley, Massachusetts

Julian Adams, PhD

Julian Adams, PhD
(2018-2020)
CEO and Chairman
Gamida-Cell
Cambridge, Massachusetts

James R. Bischoff, PhD

James R. Bischoff, PhD
(2018-2020)
Global Head Targeted Therapy-Oncology
Roche Applied Science​
Basel, Switzerland

Michael Brands, Dr. Rer.Nat

Michael Brands, Dr. Rer.Nat
(2018-2020)
Senior Vice President Drug Discovery-Small Molecule Innovation
Bayer Pharma AG​
Berlin, Germany

Sara J. Buhrlage, PhD

Sara J. Buhrlage, PhD
(2018-2020)
Assistant Professor of Biological Chemistry and Molecular Pharmacology
Dana-Farber Cancer Institute​
Boston, Massachusetts

Stephen V. Frye, PhD

Stephen V. Frye, PhD
(2017-2019)
Professor, Chemical Biology and Medicinal Chemistry
University of North Carolina at Chapel Hill​
Chapel Hill, North Carolina

Philip Jones, PhD

Philip Jones, PhD
(2017-2019)
Executive Director and Head of Drug Discovery
UT MD Anderson Cancer Center​
Houston, Texas

Vinod F. Patel, PhD

Vinod F. Patel, PhD
(2015-2019)
Chief Scientific Officer
APC Therapeutics
Acton, Massachusetts

Ian P. Street, PhD

Ian P. Street, PhD
(2017-2019)
Chief Scientfic Officer, Cancer Therapeutics CRC
Walter & Eliza Hall Institute of Medical Research​
Parkville, Parkville, VIC, Australia